Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy?

References

• Dugan JA, Bostwick DG, Myers RP, Qian J, Bergstralh EJ, Oesterling JE. The definition and preoperative prediction of clinically insignificant prostate cancer. Jama 1996; 275: 288–94
   PubMed Web of Science ®Google Scholar
• von Eschenbach AC. The biologic dilemma of early carcinoma of the prostate. Cancer 1996; 78: 326–9
   PubMedGoogle Scholar
• Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. Jama 1997; 277: 1445–51
   PubMed Web of Science ®Google Scholar
• Folkman J. The vascularization of tumors. Sci Am 1976; 234: 58–64, 70–3
   PubMed Web of Science ®Google Scholar
• Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65–71
   PubMedGoogle Scholar
• Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002; 94: 883–93
   PubMed Web of Science ®Google Scholar
• Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002; 38: 1564–79
   PubMed Web of Science ®Google Scholar
• Fox SB, Harris AL. Histological quantitation of tumour angiogenesis. Apmis 2004; 112: 413–30
   PubMedGoogle Scholar
• Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24: 220–6
   PubMed Web of Science ®Google Scholar
• Eberhard, A, Kahlert, S, Goede, V, Hemmerlein, B, Plate, KH, Augustin, HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. In: Cancer Res; 2000. p., 1388–93.
   PubMedGoogle Scholar
• Arakawa A, Soh S, Chakraborty S, Scardino PT, Wheeler TM. Prognostic significance of angiogenesis in clinically localized prostate cancer (staining for Factor VIII-related antigen and CD34 Antigen. Prostate Cancer Prostatic Dis 1997; 1: 32–38
   PubMedGoogle Scholar
• Rubin MA, Buyyounouski M, Bagiella E, Sharir S, Neugut A, Benson M, et al. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology 1999; 53: 542–7
   PubMed Web of Science ®Google Scholar
• Silberman MA, Partin AW, Veltri RW, Epstein JI. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 1997; 79: 772–9
   PubMed Web of Science ®Google Scholar
• Rogatsch H, Hittmair A, Reissigl A, Mikuz G, Feichtinger H. Microvessel density in core biopsies of prostatic adenocarcinoma: a stage predictor?. J Pathol 1997; 182: 205–10
   PubMed Web of Science ®Google Scholar
• Gleason DFatVACURG. Histologic grading and clinicalstaging of prostate carcinoma. in Urologic Pathology. The Prostate 1977:171–198.
   Google Scholar
• Norrby, K, Ridell, B. Tumour-type-specific capillary endothelial cell stainability in malignant B-cell lymphomas using antibodies against CD31, CD34 and Factor VIII. In: Apmis; 2003. p., 483–9.
   PubMedGoogle Scholar
• Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169–80
   PubMed Web of Science ®Google Scholar
• Chalkley HW. Method for quantitative morphologic analysis of tissues. J Natl Cancer Inst 1943; 4: 47–53
   Google Scholar
• Fox SB. Microscopic assessment of angiogenesis in tumors, in Angiogenesis protocols. Humana Press, Totowa, New Jersey 2001
   Google Scholar
• Pound CR, Partin AW, Epstein JI, Walsh PC. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 1997; 24: 395–406
   PubMed Web of Science ®Google Scholar
• Rioux-Leclercq NC, Chan DY, Epstein JI. Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma. Urology 2002; 60: 666–9
   PubMedGoogle Scholar
• Noguchi, M, Stamey, TA, McNeal, JE, Yemoto, CM. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 2001;166:104–9; discussion 109–10.
   PubMed Web of Science ®Google Scholar
• Halvorsen OJ, Haukaas S, Hoisaeter PA, Akslen LA. Independent prognostic importance of microvessel density in clinically localized prostate cancer. Anticancer Res 2000; 20(5C)3791–9
   PubMedGoogle Scholar
• Bettencourt MC, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. J Urol 1998; 160: 459–65
   PubMed Web of Science ®Google Scholar
• Krupski T, Petroni GR, Frierson HF, Jr, Theodorescu JU. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate. Urology 2000; 55: 743–9
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996; 48: 47–57
   PubMed Web of Science ®Google Scholar
• Djavan B, Kadesky K, Klopukh B, Marberger M, Roehrborn CG. Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur Urol 1998; 33: 261–70
   PubMed Web of Science ®Google Scholar